MTOR and cancer: Another mechanism of action of 4-HPR leading to proliferation inhibition starts with the inhibition of the mammalian target of rapamycin (mTORC2), as confirmed by the evidence that the knockdown of this protein kinase in cancer cells decreases the cytotoxicity of 4-HPR [48].